NeoGenomics, Inc. APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition
NeoGenomics, Inc. (NEO) reported APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition of $666.00 thousand for the 12-month period ending 2013-12-31, per its 10-K filed 2016-04-18.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital › APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition · last filed 2016-04-18
- NeoGenomics, Inc. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2013 was $666.00K, a 3.26% increase from fiscal 2012.
- NeoGenomics, Inc. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2012 was $645.00K, a 126.32% increase from fiscal 2011.
- NeoGenomics, Inc. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2011 was $285.00K, a 30.66% decline from fiscal 2010.
- NeoGenomics, Inc. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2010 was $411.00K.
| Period end | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 12 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 12 month as first filed |
|---|---|---|
| 2013-12-31 | $666.00K 10-K · filed 2016-04-18 | |
| 2012-12-31 | $645.00K 10-K · filed 2015-03-03 | $575.00K 10-K · filed 2013-02-21 |
| 2011-12-31 | $285.00K 10-K · filed 2014-02-24 | |
| 2010-12-31 | $411.00K 10-K · filed 2012-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |